Dr. Mahamudu Bawumia Promises Tax Reforms in Ghana Presidency

Aug.19.2024

Dr Mahamudu Bawumia, leader of Ghana's NPP, vows to scrap controversial e-cigarette and betting taxes if elected president in 2024.

According to Myjoyonline on August 18th, leader of the New Patriotic Party (NPP) in the Republic of Ghana, Dr Mahamudu Bawumia, has stated that if elected president in the 2024 general elections, he will abolish the controversial e-cigarette tax and betting tax.

During a press conference held on Sunday (the 18th), the New Patriotic Party outlined its vision for comprehensive tax reform aimed at easing the financial burden on the people of Ghana.

We will accelerate Ghana's transformation into the digital hub of Africa through strategic policies, incentive measures, and investments. This includes investing in local talent and technology startups, while also abolishing the e-cigarette tax.

If he wins the upcoming 2024 election, Bawumia has also promised to establish a more business-friendly environment.

Bawumia also outlined the comprehensive tax policies implemented by his government, which are specifically aimed at accelerating business growth and driving national economic development.

Bawumia has been serving as the Vice President of Ghana since 2017, primarily responsible for formulating government policies and overseeing their implementation.

References:

[1] Bawumia promises to abolish E-Levy and betting tax

Also Read:

[1] Fines Imposed on Ghanaian Entertainment Venues for Smoking Violations

[2] Conflicting Laws on E-cigarette Taxation in Ghana: Call for Discussion

[3] Ghana Government Implements National Tobacco Control Strategy

[4] FDA and Ghana Police Crack Down on Illegal Tobacco Activities

#Legislation #E-cigarettes #Africa #Ghana

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent

The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.

Nov.10

ACT Government Bill Targets Illicit Tobacco and Vapes with Tougher Powers

ACT Government Health Minister Rachel Stephen-Smith introduced the Tobacco and Other Smoking Products Amendment Bill 2025, expanding authorised officers’ inspection, seizure and penalty powers to address illicit tobacco and vaping. The Bill enables $1,600 infringement notices for selling prohibited smoking products and classifies illicit tobacco as a prohibited smoking product under Territory law.

Oct.23 by 2FIRSTS.ai

Malaysia CID Endorses Nationwide Vape Ban Amid Rising Drug-Laced Vape Cases

Malaysia’s Federal Criminal Investigation Department (CID) has voiced support for a nationwide ban on vaping, particularly targeting drug-laced vape devices, to address rising abuse cases.